Mechanism of action of 6, 7, s, 9, 10, 12-hexahydro-azepino-[2, 1-B] quinazolin-12-one-(RLX) - A novel bronchodilator

Indian Journal of Physiology and Pharmacology

Volumn 44, Issue 1, 2000, Pages 75-81

  Johri, R K ^a   Zutshi, U ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Anaphylaxis; Bronchodilator; Calcium uptake; Histamine

Indexed keywords

6,7,8,9,10,12 HEXAHYDROAZEPINO [2,1 B] QUINAZOLIN 12 ONE; ALKALOID DERIVATIVE; BRONCHODILATING AGENT; CYCLIC AMP PHOSPHODIESTERASE; HISTAMINE; LIPOXYGENASE; PROSTAGLANDIN E; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHODILATATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HISTAMINE RELEASE; MALE; MAST CELL DEGRANULATION; NONHUMAN; PROSTAGLANDIN RELEASE; RAT;

ANAPHYLAXIS; ANIMALS; BRONCHODILATOR AGENTS; CALCIUM; CELL DEGRANULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HISTAMINE RELEASE; HORSES; HYPERSENSITIVITY; LUNG; MALE; MAST CELLS; QUINAZOLINES; RATS;

EID: 0033950150     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Atal CK. Chemistry and Pharmacology of Vasicine - A new oxytocic and Abortifacient. Rajbandhu Publications, New Delhi, 1980: 1-151.
2. Malhotra S, Kaul SK, Singh S, Singh GB, Dhar KL. Studies on some biologically active azepinoquinazolines: part-II an approach to effective anti-inflammatory drug. Ind J Chem 1989; 28B: 100-104.
3. Singh GB, Singh S. Anti-inflammatory activity of azepino-2,[1-b] quinazolin-12(6H)-one-7, 8, 9, 19-tetrahydro (RLX). Indian Drugs 1990; 27: 449-455.
4. Sharma ML, Khajuria A, Kaul A, Chand D. Immunopharmacological properties of azepino[2, 1-b]quinazolin-12(6H)-one-7, 8, 9, 10 tetraydro (RLX). Int J Immunopharmac 1992; 14 (4): 979-986.
5. Johri RK, Zutshi U, Kameshwaran L, Atal CK. Effect of quercetin and Albizzia saponins on rat mast cell. Indian J Physiol Pharmac 1985; 29: 43-46.
6. Shore PA, Burkhalter A, Conn VH Jr. A method for the fluorometric assay of histamine in tissues. J Pharm Exp Ther 1959; 127: 182-186.
7. Brooker G, Thomas LJ, Appleman MM. The assay of adenosine 3′, 5′- cyclic monophosphate and guanosine 3′', 5′-cyclic monophosphate in biological materials by enzymatic radioisotope displacement. Biochemistry 1986; 7: 4171-4181.
8. Jaffe BM, Behraman HR. Prostaglandin E, A, and F. In: Jaffe BM, Behraman HR (eds). Methods of Harmone Radiommunoassay. 1974 New York: Academic Press: 19.
9. Bergemeyer HU. methods of Enzymatic Analysis. Academic Press, New York, 1964: 483-484.
10. Lowry OH, Rosebrough NJ, Farr AL, Randell RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1952; 193: 265-275.
11. Kusner EJ, Dubnick B, Herzig DJ. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells. J Pharm Exp Ther 1973; 184: 41-47.
12. Foreman JC, Mongar JL, Gomperts BD. A possible role for cAMP in the regulation of hisamine secretion and the action of cromoglycate. Biochem Pharmacol 1975; 24: 538-540.
13. Kaliner M, Austen KF. Cyclic nucleotides and modulation of effector system of inflammation. Biochem Pharmacol 1974; 23: 763-771.
14. Murad F. Mechanism of action of some bronchodilators; cyclic nucleotide metabolism in tracheal preparations. Ann Reu Respir Dis 1974; 10: 111-116.
15. Brocklehurst WE. The release of histamine and formation of a slow reacting substance [SRS-A] during anaphylactic shock. J Physiol 1960; 151: 416-435.
16. Rosenthale ME, Dervinis A, Kassarich J. Bronchodilator activity of the prostaglandin E1 and E2. J Pharm Exp Ther 1971; 178: 541-548.
17. Foreman JC, Mongar JL. Activation of anaphylactic histamine release by calcium and strontium ions. J Physiol 1972; 224: 753-759.